Marsh has launched a new insurance product to provide financial protection to US-based businesses and their global operations affected by an infectious disease outbreak.
PathogenRX, developed by Marsh in collaboration with Munich Re, and epidemic risk modeler Metabiota, is a fully integrated pandemic coverage.
Using triggers like Metabiota’s new Pathogen Sentiment Index, which provides extensive analytics into infectious disease outbreaks, businesses can model their potential financial loss from an outbreak and protect against the threat through an insurance policy underwritten by Munich Re. The policy is customizable and can be tailored to provide coverage for specific expenses, geographies, types of disease, or portions of a calendar year.
Bill Rossi, CEO of Metabiota, said its Pathogen Sentiment Index combines scientific knowledge with a way to measure the potential impact to consumer travel and spending as a result of an outbreak and trigger the necessary resources to offset it.
Marsh is a wholly owned subsidiary of Marsh & McLennan Companies, a global professional services firm.
Topics Profit Loss
Was this article valuable?
Here are more articles you may enjoy.
Damaged Manhattan Tower Owner to Reconstruct 15 Floors After Evacuation 
US to Explore Allowing Driverless Cars Without Steering Wheels 
El Niño Likely Strongest in 75 Years, US Forecasters Say 
Hellman & Friedman’s Hub International Seeks $3 Billion in IPO 
